LITT Technology Overview: Uses & Limitations

I hereby acknowledge that I am a healthcare provider and accept access to the NeuroBlate Ed^X portal to view physician videos on a wide variety of topics of interest to me, including but not limited to: patient selection, surgical technique, risk/benefit considerations, concomitant or competing therapies, etc.

I recognize the following:

• That this material contains individual physician commentary based on their experience at their specific institution, with their patients, and may not be representative of consensus across the clinical community;
• These videos are offered for the exchange of medical and scientific information and are not intended to direct or persuade any physician to any one practice or provide specific advice;
• Monteris Medical is not intending to make clinical or performance claims about its product that exceed the intended use cleared by FDA; and,
• The NeuroBlate device is a surgical tool and is not a treatment for any specific disease state or condition.

I also know that I can request to speak directly with any of the physicians in the videos by making a request of Monteris and receive the full instructions for use (IFU) for the NeuroBlate device by visiting Monteris.com/IFU.

The Monteris Medical NeuroBlate System is indicated for use to ablate, necrotize, or coagulate intracranial soft tissue, including brain structures (e.g., brain tumor, radiation necrosis and epileptogenic foci as identified by non-invasive and invasive neurodiagnostic testing, including imaging), through interstitial irradiation or thermal therapy in medicine and surgery in the discipline of neurosurgery with 1064 nm lasers.

The Monteris Medical NeuroBlate System is intended for planning and monitoring thermal therapies under MRI visualization. It provides MRI-based trajectory planning assistance for the stereo taxic placement of MRI compatible (conditional) NeuroBlate Laser Deliver Probes. It also provides near real-time thermographic analysis of selected MRI images.

Enter your first name, last name, and email address to opt-in for instant access and email updates.